BrightSpring Health Services Inc. (NASDAQ:BTSG) is one of the best IPO stocks to buy right now. On February 2, BTIG analyst David Larsen raised the firm’s price target for BrightSpring Health to $55 from $50 with a Buy rating. This was part of a broader research note evaluating Healthcare IT and Digital Health companies ahead of their Q4 2025 earnings. Larsen expressed a positive outlook and identified the company as a proven operator that has consistently performed well across various market cycles.
Earlier on January 27, TD Cowen analyst Charles Rhyee also raised the firm’s price target for BrightSpring Health to $46 from $42 with a Buy rating. In a Q4 2025 earnings preview, Rhyee noted that the company is expected to sustain its momentum due to strong trends in specialty generics.
BMO Capital raised its price target for BrightSpring Health Services Inc. (NASDAQ:BTSG) on January 23 to $46 from $40 with an Outperform rating. The firm’s deep-dive analysis highlights strong pharmaceutical relationships and competitive positioning, reinforcing conviction in the durable growth of the company’s specialty business.
BrightSpring Health Services Inc. (NASDAQ:BTSG) operates as a home and community-based healthcare services platform in the US. It operates through two segments: Pharmacy Solutions and Provider Services.
While we acknowledge the potential of BTSG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
